These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 716769)

  • 21. The fatty acid composition of the triglycerides in liver and subcutaneous fat in diabetics in dependence on liver fatty degeneration.
    Singer P; Gnauck G; Honigmann G
    Acta Med Pol; 1974; 15(1):27-37. PubMed ID: 4416272
    [No Abstract]   [Full Text] [Related]  

  • 22. Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver.
    Barter PJ; Nestel PJ; Carroll KF
    Metabolism; 1972 Feb; 21(2):117-24. PubMed ID: 5009387
    [No Abstract]   [Full Text] [Related]  

  • 23. Triglyceride fatty acid pattern in xanthomas, liver, adipose tissue and serum of subjects with hyperlipoproteinaemia.
    Singer P; Gnauck G; Honigmann G; Schliack V
    Acta Med Pol; 1979; 20(2):119-29. PubMed ID: 532697
    [No Abstract]   [Full Text] [Related]  

  • 24. Increase of the lipoprotein-lipase activity in human skeletal muscle during clofibrate administration.
    Lithell H; Boberg J; Hellsing K; Lundqvist G; Vessby B
    Eur J Clin Invest; 1978 Apr; 8(2):67-74. PubMed ID: 417937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty acid patterns of serum triglycerides and subcutaneous adipose tissues after ileal bypass in obesity.
    Kallner A; Hallberg D; Backman L
    Scand J Gastroenterol; 1975; 10(7):763-7. PubMed ID: 1188310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty acids incorporation into human adipose tissue in hypertriglyceridaemia.
    Carlson LA; Walldius G
    Eur J Clin Invest; 1976 Jun; 6(3):195-211. PubMed ID: 939243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The metabolism of fatty acids in diabetes].
    Bremer J
    Tidsskr Nor Laegeforen; 1971 Nov; 91(17):1296-8. PubMed ID: 4935809
    [No Abstract]   [Full Text] [Related]  

  • 28. Clofibrate in type II hyperlipoproteinemia.
    Ditzel J; Bang HO
    Acta Med Scand; 1976; 200(1-2):55-58. PubMed ID: 183462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential retention of linoleic acid-enriched triacylglycerols in liver and serum during fasting.
    Chen ZY; Cunnane SC
    Am J Physiol; 1992 Aug; 263(2 Pt 2):R233-9. PubMed ID: 1510164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fatty acid metabolism in primary hyperlipoproteinemia (HLP) (author's transl)].
    Reuter W
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(3):124-9. PubMed ID: 520271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Vessby B; Lithell H; Gustafsson IB; Borberg J
    Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
    Krut LH; Seftel HC; Joffe BI
    S Afr Med J; 1977 Mar; 51(11):348-52. PubMed ID: 323994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractional fatty acid incorporation into human adipose tissue (FIAT) in hypertriglyceridemia.
    Rubba P
    Atherosclerosis; 1978 Jan; 29(1):39-42. PubMed ID: 629825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gestational hyperlipidemia in the rat is characterized by accumulation of n - 6 and n - 3 fatty acids, especially docosahexaenoic acid.
    Chen ZY; Yang J; Cunnane SC
    Biochim Biophys Acta; 1992 Aug; 1127(3):263-9. PubMed ID: 1387324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinico-experimental long-term study on the combined effect of clofibrin and nicotinic acid on abnormal fatty acid patterns in lipid metabolism disorders in the aged].
    Reuter W
    Z Alternsforsch; 1983; 38(1):57-62. PubMed ID: 6405546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
    Jung W; Kremer GJ; Müller D
    MMW Munch Med Wochenschr; 1975 Oct; 117(44):1783-6. PubMed ID: 171564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sucrose feeding in man. Effects of substrate incorporation into hepatic triglycerides and phosphoglycerides in vitro and on removal of intravenous fat in patients with hyperlipoproteinemia.
    Cahlin E; Jönsson J; Persson B; Stakeberg H; Björntorp P; Gustafson A; Scherstén T
    Scand J Clin Lab Invest; 1973 Aug; 32(1):21-33. PubMed ID: 4358246
    [No Abstract]   [Full Text] [Related]  

  • 38. The esterification of exogenous fatty acids by adipose tissue of hypertriglyceridaemic subjects with or without diabetes mellitus.
    Clifton-Bligh P; Galton DJ
    Clin Sci Mol Med; 1976 Sep; 51(3):257-65. PubMed ID: 963955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omega-3 fatty acids in adipose tissue of obese patients with non-insulin-dependent diabetes mellitus reflect long-term dietary intake of eicosapentaenoic and docosahexaenoic acid.
    Popp-Snijders C; Blonk MC
    Am J Clin Nutr; 1995 Feb; 61(2):360-5. PubMed ID: 7840075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What happens after lipoprotein lipase? A low fatty acid incorporation into adipose tissue (FIAT) in hypertriglyceridaemia-experimental and clinical studies.
    Walldius G
    Int J Obes; 1981; 5(6):707-16. PubMed ID: 7319689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.